Article Details
Retrieved on: 2021-05-28 18:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The first poster focused on the cost-benefit analysis of preventing chemotherapy-induced myelosuppression with trilaciclib (Cosela) for this cohort of ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here